Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000666229 | SCV000790487 | uncertain significance | Deficiency of butyryl-CoA dehydrogenase | 2017-04-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000666229 | SCV001395667 | pathogenic | Deficiency of butyryl-CoA dehydrogenase | 2023-03-10 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ACADS protein function. ClinVar contains an entry for this variant (Variation ID: 551228). This missense change has been observed in individuals with short chain acyl-CoA dehydrogenase (SCAD) deficiency (PMID: 16926354, 18676165, 22424739; Invitae). This variant is present in population databases (rs777002501, gnomAD 0.04%). This sequence change replaces threonine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 169 of the ACADS protein (p.Thr169Pro). |
Baylor Genetics | RCV000666229 | SCV001526916 | uncertain significance | Deficiency of butyryl-CoA dehydrogenase | 2018-01-22 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Genome- |
RCV000666229 | SCV002033268 | uncertain significance | Deficiency of butyryl-CoA dehydrogenase | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Genetics and Molecular Pathology, |
RCV000666229 | SCV002761796 | uncertain significance | Deficiency of butyryl-CoA dehydrogenase | 2022-04-12 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000666229 | SCV003822460 | uncertain significance | Deficiency of butyryl-CoA dehydrogenase | 2022-05-30 | criteria provided, single submitter | clinical testing |